Noetic Fund
Seed and Early-Stage venture capital firm
Noetic Fund is a Seed and Early-Stage venture capital firm that invests in Biotech, Pharmaceuticals and Psychedelics. DryPowder has no SEC Form D on file for Noetic Fund as of June 3, 2026. Partners at Noetic Fund include Sa'ad Shah (Managing Partner) and Sri Teja Mullapudi (Principal, Fund Investments, Scientific Lead).
Updated · Sources: fund website
- Stages
- Seed, Early-Stage
Overview
Noetic Fund at a glance
- Stage
- Seed, Early-Stage
- Sectors
- Biotech, Pharmaceuticals, Psychedelics, Digital Health, Wellness
- Cold inbound
- Warm intro preferred
- Website
- noeticfund.com
Investment thesis
Noetic invests in early-stage technologies addressing mental health and wellbeing through novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, wearables and evidence-backed solutions targeting root causes with focus on early intervention and prevention.
Stated on noeticfund.comWEBSITE
What sets Noetic Fund apart
- Deep scientific expertise with Ph.D. scientific lead (Sri Teja Mullapudi) and pharma counsel (Richard Cheung)
- First-mover advantage in psychedelic therapeutics investment thesis (pre-FDA approval expansion)
- Global outlook spanning US, Canada, Europe
- Real-world evidence infrastructure (Victor Mifsud, Head of RWE)
What the portfolio shows
Portfolio 24
Backed: Apollo Neuroscience, Beckley Psytech, Bexson Biomedical + 21 more
Partners
5 partners at Noetic Fund
- Sri Teja Mullapudi
Principal, Fund Investments, Scientific Lead · psychedelics, neuroscience
- Victor Mifsud
Head of Real World Evidence · psychedelics, health optimization
- Yee Tan
Principal, Finance, Operations · finance, operations
Similar funds
Funds like Noetic Fund
Boost VCClimate Tech, Aerospace · $500K
Initialized CapitalSaaS, Fintech · $250K–$5M
Ada VenturesHealthtech, Climate Tech · $325K–$1.3M
PetriBiotech, Bioengineering
Pioneer FundFintech, AI/automation · $250K–$2M
Investor lists that include Noetic Fund
FAQ
Questions about Noetic Fund
What does Noetic Fund invest in?
Noetic Fund is a Seed, Early-Stage stage Biotech, Pharmaceuticals, Psychedelics, Digital health, Wellness investor, primarily investing in North America. Their thesis: Noetic invests in early-stage technologies addressing mental health and wellbeing through novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, wearables and evidence-backed solutions targeting root causes with focus on early intervention and prevention.
What makes Noetic Fund different from other funds?
Noetic Fund stands out on 4 points: Deep scientific expertise with Ph.D. scientific lead (Sri Teja Mullapudi) and pharma counsel (Richard Cheung); First-mover advantage in psychedelic therapeutics investment thesis (pre-FDA approval expansion); Global outlook spanning US, Canada, Europe; Real-world evidence infrastructure (Victor Mifsud, Head of RWE).
What other funds are similar to Noetic Fund?
Funds with an overlapping stage and sector focus include Boost VC, Initialized Capital, Ada Ventures.
How do I reach Noetic Fund?
Noetic Fund does not generally take cold inbound; a warm introduction from a founder or investor the firm knows is the usual path.
Sources
- Website: Noetic Fund website (noeticfund.com)
- Method: How DryPowder builds its data
Updated